KANEKA CORP.KK

KANEKA CORP.

22.0EURD
0.00.00%
As of today at 07:15 GMT
EUR
No trades
See on Supercharts

KKA fundamentals

Key facts

Market capitalization‪1.48 B‬EUR
Founded1949
Employees (FY)‪11.54 K‬
CEO
About

Kaneka Corp. engages in the manufacture and sale of chemicals, synthetic resins, and plastics. It operates through the following segments: Material Solutions, Quality of Life Solutions, Health Care Solutions, Nutrition Solutions and Others. The Material Solutions segment covers biodegradable polymers, materials that support the development of social infrastructure and mobility which includes the weight reduction and fuel efficiency improvement. The Quality of Life Solutions segment handles energy saving needs such as housing and living infrastructure, and development of Internet of things (IoT) and artificial intelligence (AI). The Health Care Solutions segment offers solutions through the fusion of devices and medicines, and develops healthcare business based on biopharmaceuticals and regenerative and cellular medicines. The Nutrition Solutions segment provides materials and supplement solutions to food production support in livestock and fishery industries. The Others segment provides agency services for property and life insurance. The company was founded on September 1, 1949 and is headquartered in Osaka, Japan.

Ownership
‪‪62.93 M‬‬
Free Float shares
‪‪38.04 M‬‬ (60.45%)
Closely held shares
‪‪24.89 M‬‬ (39.55%)
Free Float shares
‪‪38.04 M‬‬ (60.45%)
Closely held shares
‪‪24.89 M‬‬ (39.55%)
Capital structure
Market cap
‪‪1.48 B‬‬
Debt
‪‪1.26 B‬‬
Minority interest
‪‪124.24 M‬‬
Cash & equivalents
‪‪273.28 M‬‬
Enterprise value
‪‪2.59 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪1.48 B‬‬
Price to earning ratio (P/E)
8.27x
Price to sales ratio (P/S)
0.28x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
8.27x
Price to sales ratio (P/S)
0.28x
Valuation ratios
‪0.00‬
‪0.10‬
‪0.20‬
‪0.30‬
‪0.40‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪3.50‬
‪7.00‬
‪10.50‬
‪14.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪1.5%‬
‪2.4%‬
‪3.3%‬
‪4.2%‬
‪5.1%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪350.00 M‬‬
‪‪700.00 M‬‬
‪‪1.05 B‬‬
‪‪1.40 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪350.00 M‬‬
‪‪700.00 M‬‬
‪‪1.05 B‬‬
‪‪1.40 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪350.00 M‬‬
‪‪700.00 M‬‬
‪‪1.05 B‬‬
‪‪1.40 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Material Solutions Unit
Nutrition Solutions Unit
Quality of Life Solutions Unit
Health Care Solutions Unit
Other
By country
Period: 2023
Japan
Asia
Europe
North America
Other Regions

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪350.00 M‬‬
‪‪700.00 M‬‬
‪‪1.05 B‬‬
‪‪1.40 B‬‬
Actual
Estimate
Earnings
Next:May 20, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪0.20‬
‪0.40‬
‪0.60‬
‪0.80‬
Actual

Dividends

Dividend yield, history and sustainability

Dividend summary
26.66%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
3.44%
Last payment
0.431
Last ex-date
Mar 28, 2025
Dividend history
‪2.0%‬
‪2.5%‬
‪3.0%‬
‪3.5%‬
‪4.0%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.22‬
‪0.44‬
‪0.66‬
‪0.88‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪350.00 M‬‬
‪‪700.00 M‬‬
‪‪1.05 B‬‬
‪‪1.40 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪800.00 M‬‬
‪‪1.60 B‬‬
‪‪2.40 B‬‬
‪‪3.20 B‬‬
Assets
Liabilities